Basel Medical Group (BMGL) Competitors

$2.06 -0.18 (-8.04%)

As of 04:00 PM Eastern

BMGL vs. DCGO, XGN, CORBF, EUDA, KDLY, NAKA, QIPT, ATPC, SERA, and OPGN

Should you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include DocGo (DCGO), Exagen (XGN), Global Cord Blood (CORBF), EUDA Health (EUDA), Kindly MD (KDLY), KindlyMD (NAKA), Quipt Home Medical (QIPT), Agape ATP (ATPC), Sera Prognostics (SERA), and OpGen (OPGN). These companies are all part of the "healthcare" industry.

Basel Medical Group vs. Its Competitors

DocGo (NASDAQ:DCGO) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

: In the previous week, Basel Medical Group had 1 more articles in the media than DocGo. MarketBeat recorded 3 mentions for Basel Medical Group and 2 mentions for DocGo. DocGo's average media sentiment score of 0.42 beat Basel Medical Group's score of 0.00 indicating that DocGo is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DocGo
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Basel Medical Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: DocGo presently has a consensus target price of $3.56, indicating a potential upside of 119.75%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than Basel Medical Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DocGo
0 Sell rating(s)
3 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.50
Basel Medical Group
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: DocGo has higher revenue and earnings than Basel Medical Group.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DocGo $520.50M 0.32 $19.99M -$0.02 -81.00
Basel Medical Group $10.00M 3.80 N/A N/A N/A
: 56.4% of DocGo shares are held by institutional investors. 2.7% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: Basel Medical Group has a net margin of 0.00% compared to DocGo's net margin of -0.12%. DocGo's return on equity of 2.52% beat Basel Medical Group's return on equity.
Company Net Margins Return on Equity Return on Assets
DocGo -0.12% 2.52% 1.70%
Basel Medical Group N/A N/A N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Basel Medical Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Basel Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$520.50M	0.32	$19.99M	-$0.02	-81.00
Basel Medical Group	$10.00M	3.80	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-0.12%	2.52%	1.70%
Basel Medical Group	N/A	N/A	N/A

Summary

DocGo beats Basel Medical Group on 9 of the 12 factors compared between the two stocks.

Get Basel Medical Group News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMGL vs. The Competition

Export to Excel

Metric	Basel Medical Group	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$38.02M	$7.28B	$5.22B	$8.75B
Dividend Yield	N/A	2.83%	5.38%	4.22%
P/E Ratio	N/A	28.38	25.10	19.38
Price / Sales	3.80	25.90	397.39	117.35
Price / Cash	N/A	18.51	35.52	55.95
Price / Book	N/A	6.35	8.00	5.51
Net Income	N/A	$233.06M	$3.14B	$248.27M
7 Day Performance	-22.85%	0.23%	0.89%	0.76%
1 Month Performance	50.36%	9.49%	5.17%	4.44%
1 Year Performance	N/A	32.27%	37.49%	16.92%

Basel Medical Group Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMGL Basel Medical Group	N/A	$2.06 -8.0%	N/A	N/A	$38.02M	$10.00M	0.00	36
DCGO DocGo	2.3033 of 5 stars	$1.59 -2.2%	$3.56 +124.6%	-43.3%	$161.64M	$520.50M	-79.25	4,407
XGN Exagen	3.452 of 5 stars	$7.30 -0.9%	$7.50 +2.8%	+271.6%	$155.38M	$55.64M	-8.68	220
CORBF Global Cord Blood	N/A	$1.18 -6.3%	N/A	N/A	$143.43M	$196.12M	0.00	1,200	Gap Down
EUDA EUDA Health	0.2707 of 5 stars	$3.62 -2.9%	N/A	+28.5%	$134.49M	$4.01M	0.00	2	News Coverage
KDLY Kindly MD	N/A	$13.94 -5.9%	N/A	+429.2%	$83.95M	$2.47M	-18.10	N/A
NAKA KindlyMD	N/A	$13.42 -3.7%	N/A	N/A	$80.92M	$2.72M	-17.43	N/A
QIPT Quipt Home Medical	2.4261 of 5 stars	$1.84 +1.9%	$2.85 +55.3%	-36.7%	$79.72M	$240.85M	-8.74	1,200
ATPC Agape ATP	0.3238 of 5 stars	$1.53 flat	N/A	-70.5%	$76.31M	$1.29M	-2.54	40	News Coverage
SERA Sera Prognostics	0.4663 of 5 stars	$1.90 +1.1%	N/A	-68.7%	$71.62M	$115K	-2.02	120	Gap Up
OPGN OpGen	N/A	$4.88 flat	N/A	+94.4%	$49.13M	$2.67M	0.00	100	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMGL) was last updated on 6/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Basel Medical Group (BMGL) Competitors

BMGL vs. DCGO, XGN, CORBF, EUDA, KDLY, NAKA, QIPT, ATPC, SERA, and OPGN

Basel Medical Group vs. Its Competitors

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMGL vs. The Competition

Basel Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Basel Medical Group (BMGL) Competitors

BMGL vs. DCGO, XGN, CORBF, EUDA, KDLY, NAKA, QIPT, ATPC, SERA, and OPGN

Basel Medical Group vs. Its Competitors

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMGL vs. The Competition

Basel Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools